EUVIMEDEUVIMED entdecken
Open Access

Effects of Hedan Tablets Combined With Simvastatin on Hyperlipidemia: Insights From Microbiomics and Metabolomics

Rongrong Gao, Yumeng Zhang, Zaimei Zhang iD, Chunjie Zhao iD, Min Zhao iD

Biomedical Chromatography · 2026-09 · 40 (9)

DOI: 10.1002/bmc.70559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 28.07.2026. Verfasst von Rongrong Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Hyperlipidemias, Simvastatin, Gastrointestinal Microbiome, Drugs, Chinese Herbal. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Liaoning Provincial Department of Education Basic Scientific Research Project, Department of Science and Technology of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Simvastatin (ST) has limited long‐term clinical utility due to its adverse effects. The combination of Hedan tablets and simvastatin (HST) exhibits superior lipid‐lowering effects, but its mechanism remains unclear. This study aims to investigate the effects of HST in hyperlipidemic rats based on 16S rRNA gene sequencing and metabolomics. Gut microbiota composition was analyzed by 16S rRNA sequencing; fecal short‐chain fatty acids (SCFAs) and bile acids (BAs) in the liver and serum were quantified by GC‐MS and LC‐MS, respectively; and hepatic BA metabolism–related gene expression was detected by RT‐qPCR. 16S rRNA sequencing revealed that HST influenced gut microbiota composition and increased microbial diversity. Compared with ST, the effect of HST on SCFA levels was primarily reflected in elevated propionic acid and isovaleric acid levels, with total SCFA content significantly higher than that in the MOD group ( p < 0.001). RT‐qPCR results showed that HST‐mediated BA regulation involved the upregulation of hepatic BA synthesis genes (CYP8B1 and BACS) and the transport gene (MRP2), as well as the downregulation of reabsorption genes (NTCP and ASBT) ( p < 0.001). This study suggests that the ameliorative effect of HST on hyperlipidemia is associated with the regulation of gut microbiota and its metabolites (SCFAs and BAs).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperlipidemiasSimvastatinGastrointestinal MicrobiomeDrugs, Chinese HerbalMetabolomeAnimalsMetabolomicsRatsMaleTabletsRats, Sprague-DawleyFatty Acids, VolatileRNA, Ribosomal, 16SFecesBile Acids and SaltsLiver

Stichwörter der Autor:innen

Hedan tabletsgut microbiotahyperlipidemiametabolomics

Substanzen

SimvastatinTabletsDrugs, Chinese HerbalFatty Acids, VolatileRNA, Ribosomal, 16SBile Acids and Salts

Autor:innen und Institutionen

  • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.

ORCID-Profile: Zaimei Zhang, Chunjie Zhao, Min Zhao

Förderung

  • Liaoning Provincial Department of Education Basic Scientific Research Project
  • Department of Science and Technology of Liaoning Province

Zitieren

APA

Gao, R., Zhang, Y., Zhang, Z., Zhao, C., & Zhao, M. (2026). Effects of Hedan Tablets Combined With Simvastatin on Hyperlipidemia: Insights From Microbiomics and Metabolomics. Biomedical Chromatography, 40(9). https://doi.org/10.1002/bmc.70559

Vancouver

Gao R, Zhang Y, Zhang Z, Zhao C, Zhao M. Effects of Hedan Tablets Combined With Simvastatin on Hyperlipidemia: Insights From Microbiomics and Metabolomics. Biomedical Chromatography. 2026;40(9). doi:10.1002/bmc.70559

BibTeX
@article{Gao2026,
  author = {Gao, Rongrong and Zhang, Yumeng and Zhang, Zaimei and Zhao, Chunjie and Zhao, Min},
  title = {Effects of Hedan Tablets Combined With Simvastatin on Hyperlipidemia: Insights From Microbiomics and Metabolomics},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {9},
  doi = {10.1002/bmc.70559}
}
Kostenlos starten →